TERT and hepatocellular carcinoma: Preclinical studies have demonstrated that CRISPR-mediated TERT knockout in HCC cell lines leads to significant reductions in proliferation and increased apoptosis, but challenges remain regarding delivery mechanisms, off-target effects, and long-term safety [45,46].